Vivimed Labs acquires Uquifa Spain and Uquifa Mexico

01 Dec 2011 Evaluate

In a move to bring in strategic growth into its product mix and expand the footprint in Europe and the America, Vivimed Labs has acquired Uquifa Spain and Uquifa Mexico, a 75-year-old manufacturer of pharma APIs and intermediates with operations in Spain and Mexico.

This move would strengthen the company’s current position in pharma APIs and intermediates while significantly improving the cost competitiveness of Uquifa. While Uquifa gets the supply side efficiencies and knowledge base of Vivimed in pharma, Vivimed would leverage the preeminent position of Uquifa in APIs and their robust pipeline of filings to accelerate growth across Europe and the Americas in the next five years.

The acquisition of Uquifa will add to Vivimed’s multi-geographical locations and knowledge base. This will fundamentally mean greater comfort levels for customers and channel partners. The Uquifa acquisition in Europe comes after 2008, post a successful acquisition and integration of James Robinson in UK.

Vivimed Labs is engaged in the business of manufacturing ingredients for the home and personal care (H&PC) industry and Contract Research and Manufacturing Services (CRAMS). It carries on its business from 4 manufacturing facilities which are located at Bidar (Karnataka), Jeedimetla (Hyderabad), Bonthapally (Hyderabad) and Kashipur (Uttaranchal).

Vivimed Labs Share Price

5.75 0.00 (0.00%)
31-Jul-2023 18:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×